This is a review about c-Met, based on 24 published articles (read how Labome selects the articles), using c-Met antibody in all methods. It is aimed to help Labome visitors find the most suited c-Met antibody.
c-Met synonym: AUTS9; HGFR; RCCP2; c-Met; HGF receptor; HGF/SF receptor; SF receptor; hepatocyte growth factor receptor; met proto-oncogene tyrosine kinase; proto-oncogene c-Met; scatter factor receptor; tyrosine-protein kinase Met

Santa Cruz BiotechnologySanta Cruz Biotechnology c-Met product
  • block or activateIn 2003, Shunli Ding et al. applied Santa Cruz Biotechnology c-Met antibody to study the role of the endogenous HGF/c-met system in one or more steps of the angiogenic process [ncbi , more ].
  • flow cytometryIn 2009, Bradley Pawlikowski et al. utilized Santa Cruz Biotechnology c-Met antibody to perform immunohistochemistry in order to study the role of Pax7 in human satellite stem cell differentiation and self renewal [ncbi , more ].
  • immunocytochemistryIn 2003, Shunli Ding et al. applied Santa Cruz Biotechnology c-Met antibody to study the role of the endogenous HGF/c-met system in one or more steps of the angiogenic process [ncbi , more ].
  • immunohistochemistryIn 2009, Bradley Pawlikowski et al. utilized Santa Cruz Biotechnology c-Met antibody to perform immunohistochemistry in order to study the role of Pax7 in human satellite stem cell differentiation and self renewal [ncbi , more ]. In 2006, Mehmet Uzumcu et al. employed Santa Cruz Biotechnology c-Met antibody to investigate the distribution of HGF, c-met, and HGF activator (HGFA) protein during folliculogenesis in equine chorionic gonadotropin (eCG) primed rats [ncbi , more ]. Rina Nanba et al. used Santa Cruz Biotechnology c-Met antibody to study HGF expression in cerebrospinal fluid and intracranial artery in moyamoya disease [ncbi , more ] in 2004 and Donna E Hansel et al. used Santa Cruz Biotechnology c-Met antibody to investigate Met expression in human nonmetastatic and metastatic well-differentiated pancreatic endocrine neoplasms [ncbi , more ]. In 2003, Yiwen Li et al. applied Santa Cruz Biotechnology c-Met antibody to study the effect of adenoviral vector expressing hepatocyte growth factor on chronic left ventricular remodeling and dysfunction in mice [ncbi , more ].
  • immunoprecipitationSanta Cruz Biotechnology c-Met antibody was employed in 2003 to isolate Met from COS cells and human GTL16 cells, and in western blot to detect Met levels in COS cells, mouse NIH3T3 cells and human A549 lung carcinoma cells [ncbi , more ], to study the effect of adenoviral vector expressing hepatocyte growth factor on chronic left ventricular remodeling and dysfunction in mice [ncbi , more ]and to detect h-Met in SK-LMS-1 cells and MDA-MB-231 cells with TSP1 transfection [ncbi , more ]. Gregory I Liou et al. applied Santa Cruz Biotechnology c-Met antibody to study the role for MAP kinase and beta-catenin signaling in HGF induced RPE migration in human ARPE-19 cells and RPE cells [ncbi , more ] in 2002 and Gautam Maulik et al. used Santa Cruz Biotechnology c-Met antibody to study the role of the c-Met/hepatocyte growth factor pathway in small cell lung cancer [ncbi , more ]. In 2001, S Fan et al. employed Santa Cruz Biotechnology c-Met antibody to study the HGF/SF-c-Met signaling pathways for cell survival and DNA repair regulated by Gab1 (catalog: sc-162) [ncbi , more ].
  • western blotIn 2009, Haggar Harduf et al. utilized Santa Cruz Biotechnology c-Met antibody to do western blot in order to investigate the role of the progesterone receptor A and c-Met in spheroids-endometrium [ncbi , more ]. In 2007, David L Shattuck et al. used Santa Cruz Biotechnology c-Met antibody to identify LRIG1 as a novel negative regulator of the Met receptor and its role on opposing Met and Her2 synergy [ncbi , more ]. In 2006, Mehmet Uzumcu et al. employed Santa Cruz Biotechnology c-Met antibody to investigate the distribution of HGF, c-met, and HGF activator (HGFA) protein during folliculogenesis in equine chorionic gonadotropin (eCG) primed rats [ncbi , more ]. In 2005, Kentaro Kajiya et al. used Santa Cruz Biotechnology c-Met antibody to study the role for hepatocyte growth factor in promoting lymphatic vessel formation and function in human dermal BVEC and LEC [ncbi , more ]. Kerstin Schag et al. employed Santa Cruz Biotechnology c-Met antibody to determine c-Met expression in human MCF-7 breast cancer cells, A498 renal cell carcinoma, MZ1257 renal cell carcinoma, U266 multiple myeloma, HCT116 colon cancer cells, Mel1479 malignant melanoma, SK-OV-3 ovarian cells, T2 cells and Croft EBV-immortalized B-cell line (catalog: sc-161) [ncbi , more ] in 2004 and Debora Angeloni et al. used Santa Cruz Biotechnology c-Met antibody to study the role for the sema domain of RON in ligand binding by the full-length receptor. [ncbi , more ]. Santa Cruz Biotechnology c-Met antibody was utilized in 2003 to isolate Met from COS cells and human GTL16 cells, and in western blot to detect Met levels in COS cells, mouse NIH3T3 cells and human A549 lung carcinoma cells [ncbi , more ], to study the role for PKC in controlling traffic pathway for c-Met that operates independently of its degradative pathway [ncbi , more ], to study the effect of adenoviral vector expressing hepatocyte growth factor on chronic left ventricular remodeling and dysfunction in mice [ncbi , more ], to study the role of the endogenous HGF/c-met system in one or more steps of the angiogenic process [ncbi , more ]and to detect h-Met in SK-LMS-1 cells and MDA-MB-231 cells with TSP1 transfection [ncbi , more ]. Gregory I Liou et al. applied Santa Cruz Biotechnology c-Met antibody to study the role for MAP kinase and beta-catenin signaling in HGF induced RPE migration in human ARPE-19 cells and RPE cells [ncbi , more ] in 2002 and Gautam Maulik et al. used Santa Cruz Biotechnology c-Met antibody to study the role of the c-Met/hepatocyte growth factor pathway in small cell lung cancer [ncbi , more ]. In 2001, S Fan et al. employed Santa Cruz Biotechnology c-Met antibody to study the HGF/SF-c-Met signaling pathways for cell survival and DNA repair regulated by Gab1 (catalog: sc-162) [ncbi , more ].
Cell Signaling TechnologyCell Signaling Technology c-Met product
  • immunohistochemistryIn 2009, Deliang Guo et al. applied Cell Signaling Technology c-Met antibody to investigate the mechanism of how Akt mediates sterol regulatory element-binding protein 1 (SREBP-1) cleavage induced by EGFR [ncbi , more ].
  • western blotIn 2006, Gael G McGill et al. used Cell Signaling Technology c-Met antibody to detect the phosphorylation of Met in primary neonatal human melanocytes [ncbi , more ]. In 2005, Xiaoyan Wen et al. employed Cell Signaling Technology c-Met antibody to study the effects of 9-cis-RA on glomerular mesangial cell activation induced by transforming growth factor (TGF) beta1 [ncbi , more ]. In 2003, Lisa S Lock et al. employed Cell Signaling Technology c-Met antibody to study the Gab1 recruitment into a multiprotein signaling complex through Met [ncbi , more ].
EMD MilliporeEMD Millipore c-Met product
  • immunocytochemistryIn 2003, Stephanie Kermorgant et al. used EMD Millipore c-Met antibody to study the role for PKC in controlling traffic pathway for c-Met that operates independently of its degradative pathway [ncbi , more ].
  • western blotIn 2007, David L Shattuck et al. used EMD Millipore c-Met antibody to identify LRIG1 as a novel negative regulator of the Met receptor and its role on opposing Met and Her2 synergy [ncbi , more ]. In 2006, Gael G McGill et al. employed EMD Millipore c-Met antibody to detect Met in primary neonatal human melanocytes [ncbi , more ]. In 2003, Lisa S Lock et al. employed EMD Millipore c-Met antibody to study the Gab1 recruitment into a multiprotein signaling complex through Met [ncbi , more ]. In 2002, Michael Mildner et al. used EMD Millipore c-Met antibody to study the inhibition of UVB-induced apoptosis of human keratinocytes by hepatocyte growth factor/satter factor [ncbi , more ].
R and D SystemsR and D Systems c-Met product
  • block or activateIn 2005, Kentaro Kajiya et al. used R and D Systems c-Met antibody to study the role for hepatocyte growth factor in promoting lymphatic vessel formation and function in human dermal BVEC and LEC [ncbi , more ].
  • immunohistochemistryIn 2009, Janine A Burns et al. employed R and D Systems c-Met antibody to perform immunohistochemistry in order to study the function of the fixative in the immunohistochemical detection of phosphoproteins [ncbi , more ].
  • immunoprecipitationIn 2005, Kentaro Kajiya et al. used R and D Systems c-Met antibody to study the role for hepatocyte growth factor in promoting lymphatic vessel formation and function in human dermal BVEC and LEC [ncbi , more ].
Life Technologies CorporationLife Technologies Corporation c-Met product
  • immunoprecipitationIn 2009, Rajani Kanteti et al. employed Life Technologies Corporation c-Met antibody to demostrate the expression of PAX 5 and the regulation for c-Met transcription in small cell lung cancer [ncbi , more ].
  • western blotIn 2009, Rajani Kanteti et al. employed Life Technologies Corporation c-Met antibody to demostrate the expression of PAX 5 and the regulation for c-Met transcription in small cell lung cancer [ncbi , more ].
Abgent
  • immunohistochemistryIn 2009, Deliang Guo et al. applied Abgent c-Met antibody to investigate the mechanism of how Akt mediates sterol regulatory element-binding protein 1 (SREBP-1) cleavage induced by EGFR [ncbi , more ].
Articles Reviewed
  1. Deliang Guo et al. (2009). "EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy".PMID 20009104
  2. Haggar Harduf et al. (2009). "Progesterone receptor A and c-Met mediates spheroids-endometrium attachment".PMID 19220894
  3. Rajani Kanteti et al. (2009). "PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription".PMID 19139719
  4. Bradley Pawlikowski et al. (2009). "Analysis of human muscle stem cells reveals a differentiation-resistant progenitor cell population expressing Pax7 capable of self-renewal".PMID 19097049
  5. Janine A Burns et al. (2009). "Choice of fixative is crucial to successful immunohistochemical detection of phosphoproteins in paraffin-embedded tumor tissues".PMID 19001637
  6. David L Shattuck et al. (2007). "LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy".PMID 17178829
  7. Mehmet Uzumcu et al. (2006). "Immunolocalization of the hepatocyte growth factor (HGF) system in the rat ovary and the anti-apoptotic effect of HGF in rat ovarian granulosa cells in vitro".PMID 16885537
  8. Gael G McGill et al. (2006). "c-Met expression is regulated by Mitf in the melanocyte lineage".PMID 16455654
  9. Xiaoyan Wen et al. (2005). "Hepatocyte growth factor receptor signaling mediates the anti-fibrotic action of 9-cis-retinoic acid in glomerular mesangial cells".PMID 16192631
  10. Kentaro Kajiya et al. (2005). "Hepatocyte growth factor promotes lymphatic vessel formation and function".PMID 16052207
  11. Rina Nanba et al. (2004). "Increased expression of hepatocyte growth factor in cerebrospinal fluid and intracranial artery in moyamoya disease".PMID 15528455
  12. Donna E Hansel et al. (2004). "Met proto-oncogene and insulin-like growth factor binding protein 3 overexpression correlates with metastatic ability in well-differentiated pancreatic endocrine neoplasms".PMID 15448002
  13. Kerstin Schag et al. (2004). "Identification of C-met oncogene as a broadly expressed tumor-associated antigen recognized by cytotoxic T-lymphocytes".PMID 15173072
  14. Debora Angeloni et al. (2004). "The soluble sema domain of the RON receptor inhibits macrophage-stimulating protein-induced receptor activation".PMID 14597639
  15. Yu wen Zhang et al. (2003). "Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation".PMID 14555767
  16. Lisa S Lock et al. (2003). "Grb2-independent recruitment of Gab1 requires the C-terminal lobe and structural integrity of the Met receptor kinase domain".PMID 12766170
  17. Federica Chiara et al. (2003). "Mutations in the met oncogene unveil a "dual switch" mechanism controlling tyrosine kinase activity".PMID 12746450
  18. Stephanie Kermorgant et al. (2003). "Protein kinase C controls microtubule-based traffic but not proteasomal degradation of c-Met".PMID 12716900
  19. Yiwen Li et al. (2003). "Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice".PMID 12695295
  20. Shunli Ding et al. (2003). "HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro".PMID 12595309
  21. Gregory I Liou et al. (2002). "MAP kinase and beta-catenin signaling in HGF induced RPE migration".PMID 12500177
  22. Gautam Maulik et al. (2002). "Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer".PMID 11839685
  23. Michael Mildner et al. (2002). "Hepatocyte growth factor/scatter factor inhibits UVB-induced apoptosis of human keratinocytes but not of keratinocyte-derived cell lines via the phosphatidylinositol 3-kinase/AKT pathway".PMID 11821397
  24. S Fan et al. (2001). "The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair".PMID 11438654